Page 150 - MI-2-3
P. 150

Microbes & Immunity                                                   Characterizing low-grade CNS tumors



            Funding                                            References

            This work was supported by the Council of Scientific   1.   Dasgupta A, Gupta T, Jalali R. Indian data on central
            and Industrial Research (CSIR), Government of India,   nervous tumors: A summary of published work. South Asian
            through Project No.  37(1587)/13/EMR-II, and was      J Cancer. 2016;5(3):147-153.
            partially supported by the Indian Council of Medical      doi: 10.4103/2278-330X.187589
            Research (ICMR) under project grant No.  61/8/2011-  2.   Ghosh A, Sarkar S, Begum Z, et al. The first cross sectional
            BMS, awarded to Dr.  Anirban Ghosh as principal       survey on intracranial malignancy in Kolkata, India:
            investigator.                                         Reflection of the State of the art in Southern West Bengal.
                                                                  Asian Pacific J Cancer Prev. 2004;5(3):259.
            Conflict of interest
                                                               3.   Jalali R, Datta D. Prospective analysis of incidence of central
            The authors declare they have no competing interests.  nervous tumors presenting in a tertiary cancer hospital from
                                                                  India. J Neurooncol. 2008;87(1):111-114.
            Author contributions
                                                                  doi: 10.1007/S11060-007-9487-Z
            Conceptualization: Anirban Ghosh                   4.   Paul M, Goswami S, Goutham Raj C, Bora G. Clinico-
            Data curation: Krishnendu Ghosh                       epidemiological profile of primary brain tumours in North-
            Formal analysis: Krishnendu Ghosh                     Eastern  region  of  India:  A  retrospective  single  institution
            Funding acquisition: Anirban Ghosh                    study. Asian Pacific J Cancer Care. 2023;8(2):333-336.
            Investigation: Krishnendu Ghosh, Anirban Ghosh        doi: 10.31557/apjcc.2023.8.2.333-336
            Methodology: Krishnendu Ghosh
            Project administration: Anirban Ghosh              5.   Yeole BB. Trends in the brain cancer incidence in India.
            Resources: Pritha Bhattacharjee, Anirban Ghosh        Asian Pac J Cancer Prev. 2008;9(2):267-270.
            Supervision: Pritha Bhattacharjee, Anirban Ghosh   6.   Miller KD, Ostrom QT, Kruchko C, et al. Brain and other
            Validation:  Pritha  Bhattacharjee,  Anirban Ghosh,   central nervous system tumor statistics, 2021. CA A Cancer
               Krishnendu Ghosh                                   J Clin. 2021;71(5):381-406.
            Writing – original draft: Krishnendu Ghosh            doi: 10.3322/CAAC.21693
            Writing – review & editing: All authors
                                                               7.   Gao H, Jiang X. Progress on the diagnosis and evaluation of
            Ethics approval and consent to participate            brain tumors. Cancer Imaging. 2013;13(4):466-481.
                                                                  doi: 10.1102/1470-7330.2013.0039
            The present study involved collection of post-operative
            human tumor samples, which was approved by the     8.   Park SH, Won J, Kim SI, et al. Molecular testing of brain
            Institutional Ethical Committee (IEC) at the Institute   tumor. J Pathol Transl Med. 2017;51(3):205-223.
            of Post Graduate Medical Education and Research       doi: 10.4132/jptm/2017.03.08
            (IPGME&R), Kolkata, West Bengal, India (Human Ethical   9.   Louis DN, Perry A, Reifenberger G,  et al. The 2016
            Clearance Memo No: Inst/IEC/553 dated January 15,     World Health Organization classification of tumors of the
            2014). The specimen collection was performed together   central nervous system: A  summary.  Acta Neuropathol.
            with our collaborating neurosurgeon and clinical      2016;131(6):803-820.
            pathologist mentioned in the Acknowledgments section.      doi: 10.1007/s00401-016-1545-1
            Informed consent was obtained from the human subjects
            (patients’ next keen) abiding by the World Medical   10.  Louis DN, Perry A, Wesseling P,  et al. The 2021 WHO
                                           th
            Association- Declaration of Helsinki, 64  general assembly,   classification  of  tumors  of  the  central  nervous  system:
            Brazil, 2013.                                         A summary. Neuro Oncol. 2021;23(8):1231-1251.
                                                                  doi: 10.1093/neuonc/noab106
            Consent for publication
                                                               11.  Sincevičiūtė R, Vaitkienė P, Urbanavičiūtė R, Steponaitis G,
            Informed consent was obtained from the human subjects   Tamašauskas A, Skiriutė D. MMP2 is associated with glioma
            (patients’ next keen) to publish their data.          malignancy and patient outcome.  Int J Clin Exp Pathol.
                                                                  2018;11(6):3010-3018.
            Availability of data                               12.  Seyedmirzaei H, Shobeiri P, Turgut M, Hanaei S, Rezaei N.
            All the materials are owned by the authors and will be   VEGF levels in patients with glioma: A systematic review
            available from the corresponding authors upon reasonable   and meta-analysis. Rev Neurosci. 2020;32(2):191-202.
            request.                                              doi: 10.1515/revneuro-2020-0062


            Volume 2 Issue 3 (2025)                        142                           doi: 10.36922/MI025190040
   145   146   147   148   149   150   151   152   153   154   155